MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 27, 2004; DOI: 10.1124/mol.104.003624


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.003624v1
67/2/460    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by El-Asmar, L.
Right arrow Articles by Parmentier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by El-Asmar, L.
Right arrow Articles by Parmentier, M.


Received for publication June 14, 2004.
Revised October 26, 2004.
Accepted for publication October 26, 2004.

Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers

Laila El-Asmar 1, Jean-Yves Springael 1, Sebastien Ballet 1, Eneko Urizar Andrieu 1, Gilbert Vassart 1, Marc Parmentier 1*

1 ULB

* Address correspondence to: E-mail: mparment{at}ulb.ac.be

Abstract

It is well established that most G protein-coupled receptors are able to form homo- and heterodimers, although the functional consequences of this process often remain unclear. CCR5 is a chemokine receptor that plays an important role in inflammatory diseases, and acts as a major co-receptor for human immunodeficiency viruses (HIV). CCR5 was previously shown to homodimerize and heterodimerize with CCR2b, a closely related receptor. In the present study, we have analyzed the functional consequences of this dimerization process, in terms of ligand binding, stimulation of intracellular cascades and internalization. BRET and co-immunoprecipitation assays demonstrated that CCR5 and CCR2b heterodimerize with the same efficiency as they homodimerize. In contrast to what has been reported earlier, no cooperative signaling was observed following co-stimulation of the two receptors by their respective ligands. However, we observed that CCR5-specific ligands which are unable to compete for MCP-1 binding on cells expressing CCR2b alone, efficiently prevented MCP-1 binding when CCR5 and CCR2b were co-expressed. The extent of this cross-competition was correlated with the amount of CCR5 expressed in cells, as determined by FACS analysis. Similar observations were made for the CCR2b-selective ligand MCP-1, that competed efficiently for MIP-1{beta} binding on cells expressing both receptors. Internalization assays did not allow us to demonstrate co-internalization of the receptors in response to agonist stimulation. Taken together, our observations suggest that CCR5 and CCR2b form homo- and heterodimers with similar efficiencies, and that a receptor dimer can only bind a single chemokine.


Key words: Chemotactic peptides, Gi family, Calcium (G Protein Coupled Signals), Structure-activity relationships and modeling, Fluorescence techniques, Receptor binding studies





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics